{
    "output": [
        [
            "J.P. Morgan Healthcare Conference",
            "EVENT",
            "Participates_In",
            "Healthcare Sector",
            "SECTOR"
        ],
        [
            "Executives",
            "PERSON",
            "Has",
            "New Federal Tax Law",
            "ORG/GOV"
        ],
        [
            "Biotech and Pharmaceutical Firm",
            "COMP",
            "Has",
            "New Corporate Tax Rate",
            "ECON_INDICATOR"
        ],
        [
            "Biotech and Pharmaceutical Firm",
            "COMP",
            "Has",
            "Overseas Cash",
            "FIN_INSTRUMENT"
        ],
        [
            "Analysts",
            "PERSON",
            "Predict",
            "Spike in Dealmaking",
            "EVENT"
        ],
        [
            "Companies",
            "COMP",
            "Insist",
            "Influx of Cash",
            "FIN_INSTRUMENT",
            "DoesNotChange",
            "Plans for Capital",
            "CONCEPT"
        ],
        [
            "Johnson & Johnson",
            "COMP",
            "Has",
            "Globally Competitive System",
            "CONCEPT"
        ],
        [
            "Johnson & Johnson",
            "COMP",
            "Benefit",
            "U.S. Economy",
            "CONCEPT"
        ],
        [
            "Johnson & Johnson",
            "COMP",
            "Benefit",
            "Job Creation in U.S.",
            "CONCEPT"
        ],
        [
            "Johnson & Johnson",
            "COMP",
            "Has",
            "Dominic Caruso",
            "PERSON",
            "As",
            "Chief Financial Officer"
        ],
        [
            "Johnson & Johnson",
            "COMP",
            "Operate_In",
            "Healthcare Sector",
            "SECTOR"
        ],
        [
            "Johnson & Johnson",
            "COMP",
            "Has",
            "Dividend",
            "CONCEPT"
        ],
        [
            "Johnson & Johnson",
            "COMP",
            "Has",
            "Mergers",
            "EVENT"
        ],
        [
            "Johnson & Johnson",
            "COMP",
            "Has",
            "Share Buybacks",
            "CONCEPT"
        ],
        [
            "Johnson & Johnson",
            "COMP",
            "Has",
            "More Globally Competitive System",
            "CONCEPT"
        ],
        [
            "Johnson & Johnson",
            "COMP",
            "Will Benefit",
            "U.S. Economy",
            "CONCEPT"
        ],
        [
            "Johnson & Johnson",
            "COMP",
            "Will Benefit",
            "Job Creation in U.S.",
            "CONCEPT"
        ],
        [
            "Johnson & Johnson",
            "COMP",
            "Has",
            "First Priority",
            "CONCEPT",
            "Of",
            "Dividend"
        ],
        [
            "Johnson & Johnson",
            "COMP",
            "Has",
            "Mergers and Share Buybacks",
            "CONCEPT"
        ],
        [
            "Medtronic",
            "COMP",
            "Has",
            "Medical Device Giant",
            "COMP"
        ],
        [
            "Medtronic",
            "COMP",
            "Has",
            "Omar Ishrak",
            "PERSON",
            "As",
            "CEO"
        ],
        [
            "Medtronic",
            "COMP",
            "Has",
            "New Law",
            "ORG/GOV",
            "Allows",
            "Access Nearly All of Cash"
        ],
        [
            "Medtronic",
            "COMP",
            "Has",
            "Repatriation",
            "CONCEPT",
            "Between",
            "$2 Billion and $3 Billion",
            "FIN_INSTRUMENT"
        ],
        [
            "Medtronic",
            "COMP",
            "Will Focus on",
            "Reinvesting",
            "CONCEPT",
            "To Offset Cost"
        ],
        [
            "Celgene",
            "COMP",
            "Has",
            "Biotech Company",
            "COMP"
        ],
        [
            "Celgene",
            "COMP",
            "Has",
            "Mark Alles",
            "PERSON",
            "As",
            "CEO"
        ],
        [
            "Celgene",
            "COMP",
            "Has",
            "Changes",
            "CONCEPT",
            "Allows",
            "Access About 60 Percent of Cash"
        ],
        [
            "Celgene",
            "COMP",
            "Has",
            "One-Time Tax",
            "ECON_INDICATOR",
            "Between",
            "$800 Million and $1.3 Billion"
        ],
        [
            "Celgene",
            "COMP",
            "Announce",
            "Buy Impact Biomedicines",
            "PRODUCT"
        ],
        [
            "Companies",
            "COMP",
            "May Clarify",
            "How Law Will Affect Them",
            "CONCEPT"
        ]
    ]
}